Vir Biotechnology (VIR) Goodwill & Intangibles (2018 - 2026)

Vir Biotechnology recorded quarterly Goodwill & Intangibles of $24.7 million in Q1 2026, little changed quarter-over-quarter from $24.8 million in Q4 2025, and down 1.18% year-over-year from $25.0 million in Q1 2025.

Vir Biotechnology's Goodwill & Intangibles history runs 9 years deep, the most recent figure standing at $24.7 million for Q1 2026.

  • In Q1 2026, Goodwill & Intangibles fell 1.18% year-over-year to $24.7 million; the TTM figure through Mar 2026 stood at $24.7 million (down 1.18% YoY), while the FY2025 annual figure was $24.8 million, down 1.08% from the prior year.
  • Goodwill & Intangibles came in at $24.7 million for Q1 2026 at Vir Biotechnology, roughly flat from $24.8 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $50.1 million in Q1 2022 to a low of $24.7 million in Q1 2026.
  • A 5-year average of $37.3 million and a median of $39.4 million in 2024 frame the typical range for Goodwill & Intangibles.
  • Across the five-year window, Goodwill & Intangibles dropped 1.05% in 2022 and tumbled 36.57% in 2024, its largest moves.
  • Vir Biotechnology's Goodwill & Intangibles stood at $49.7 million in 2022, then retreated by 20.51% to $39.5 million in 2023, then plunged by 36.57% to $25.1 million in 2024, then dropped by 1.08% to $24.8 million in 2025, then dropped by 0.29% to $24.7 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $24.7 million, $24.8 million, and $24.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Vir Biotechnology 1.33 Bn 1.33 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 24.71 Mn
Dec 31, 2025 24.79 Mn
Sep 30, 2025 24.86 Mn
Jun 30, 2025 24.94 Mn
Mar 31, 2025 25.01 Mn
Dec 31, 2024 25.06 Mn
Sep 30, 2024 36.20 Mn
Jun 30, 2024 35.84 Mn
Mar 31, 2024 39.40 Mn
Dec 31, 2023 39.50 Mn
Sep 30, 2023 42.39 Mn
Jun 30, 2023 42.53 Mn
Mar 31, 2023 49.56 Mn
Dec 31, 2022 49.69 Mn
Sep 30, 2022 49.83 Mn
Jun 30, 2022 49.96 Mn
Mar 31, 2022 50.09 Mn
Dec 31, 2021 50.22 Mn
Sep 30, 2021 50.36 Mn
Jun 30, 2021 50.49 Mn
Mar 31, 2021 50.62 Mn
Dec 31, 2020 50.76 Mn
Sep 30, 2020 50.84 Mn
Jun 30, 2020 52.02 Mn
Mar 31, 2020 52.33 Mn
Dec 31, 2019 52.63 Mn
Sep 30, 2019 52.94 Mn
Dec 31, 2018 53.85 Mn